Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (631-640 of 710) with videos related to

Pageof 71
Sort By:
ERJ Open Research|April 21, 2022
Respiratory symptoms and radiological findings in post-acute COVID-19 syndromeEtienne-Marie Jutant, Olivier Meyrignac, Antoine Beurnier, et al.
European Journal of Internal Medicine|May 15, 2015
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and managementMatthieu Groh, Christian Pagnoux, Chiara Baldini, et al.
The European Respiratory Journal|January 6, 2021
Imaging of pulmonary hypertension in adults: a position paper from the Fleischner SocietyMartine Remy-Jardin, Christopher J Ryerson, Mark L Schiebler, et al.
The Lancet. Respiratory Medicine|February 23, 2025
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patientsFranck F Rahaghi, Marc Humbert, Marius M Hoeper, et al.
The European Respiratory Journal|September 11, 2023
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trialRogerio Souza, David B Badesch, H Ardeschir Ghofrani, et al.
Circulation Research|December 17, 2013
Evidence for the involvement of type I interferon in pulmonary arterial hypertensionPeter M George, Eduardo Oliver, Peter Dorfmuller, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2005
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionElisabeth D Willers, John H Newman, James E Loyd, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
Pageof 71

Showing results (631-640 of 710) with videos related to

Sort By:
Pageof 71
ERJ Open Research|April 21, 2022
Respiratory symptoms and radiological findings in post-acute COVID-19 syndromeEtienne-Marie Jutant, Olivier Meyrignac, Antoine Beurnier, et al.
European Journal of Internal Medicine|May 15, 2015
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and managementMatthieu Groh, Christian Pagnoux, Chiara Baldini, et al.
The European Respiratory Journal|January 6, 2021
Imaging of pulmonary hypertension in adults: a position paper from the Fleischner SocietyMartine Remy-Jardin, Christopher J Ryerson, Mark L Schiebler, et al.
The Lancet. Respiratory Medicine|February 23, 2025
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patientsFranck F Rahaghi, Marc Humbert, Marius M Hoeper, et al.
The European Respiratory Journal|September 11, 2023
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trialRogerio Souza, David B Badesch, H Ardeschir Ghofrani, et al.
Circulation Research|December 17, 2013
Evidence for the involvement of type I interferon in pulmonary arterial hypertensionPeter M George, Eduardo Oliver, Peter Dorfmuller, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2005
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionElisabeth D Willers, John H Newman, James E Loyd, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
Pageof 71